Howard Hughes Medical Institute’s TSMC TSM Stock Holding History

Howard Hughes Medical Institute’s Portfolio TSM Stock Details TSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.6M	Buy	+66,773	New	+$23M	5.43%	7
2023 Q1	–	Sell	-100,000	Closed	-$7.45M	–	18
2022 Q4	$7.45M	Hold	100,000	–	–	4.15%	11
2022 Q3	$6.86M	Hold	100,000	–	–	1.95%	22
2022 Q2	$8.18M	Buy	100,000 +10,000	+11%	+$925K	4.42%	11
2022 Q1	$9.38M	Hold	90,000	–	–	4.11%	11
2021 Q4	$10.8M	Hold	90,000	–	–	4.24%	9
2021 Q3	$10M	Hold	90,000	–	–	3.39%	13
2021 Q2	$10.8M	Hold	90,000	–	–	3.62%	9
2021 Q1	$10.6M	Sell	90,000 -20,000	-18%	-$2.48M	3.62%	11
2020 Q4	$12M	Sell	110,000 -20,000	-15%	-$1.9M	2.81%	9
2020 Q3	$10.5M	Sell	130,000 -20,000	-13%	-$1.52M	3.46%	9
2020 Q2	$8.52M	Hold	150,000	–	–	3.48%	10
2020 Q1	$7.17M	Hold	150,000	–	–	1.5%	12
2019 Q4	$8.71M	Hold	150,000	–	–	3.12%	8
2019 Q3	$6.97M	Hold	150,000	–	–	1.95%	10
2019 Q2	$5.88M	Hold	150,000	–	–	2.81%	11
2019 Q1	$6.14M	Hold	150,000	–	–	1.43%	11
2018 Q4	$5.54M	Hold	150,000	–	–	1.75%	13
2018 Q3	$6.62M	Hold	150,000	–	–	1.93%	11
2018 Q2	$5.48M	Hold	150,000	–	–	1.39%	14
2018 Q1	$6.56M	Hold	150,000	–	–	1.71%	10
2017 Q4	$5.95M	Hold	150,000	–	–	1.54%	12
2017 Q3	$5.63M	Hold	150,000	–	–	1.4%	15
2017 Q2	$5.24M	Hold	150,000	–	–	0.96%	24
2017 Q1	$4.93M	Hold	150,000	–	–	0.91%	26
2016 Q4	$4.31M	Sell	150,000 -125,000	-45%	-$3.76M	0.99%	24
2016 Q3	$8.41M	Hold	275,000	–	–	2.17%	6
2016 Q2	$7.21M	Sell	275,000 -100,000	-27%	-$2.5M	2.42%	11
2016 Q1	$9.82M	Hold	375,000	–	–	2.17%	4
2015 Q4	$8.53M	Sell	375,000 -55,000	-13%	-$1.24M	1.3%	6
2015 Q3	$8.92M	Buy	430,000 +45,000	+12%	+$945K	1.67%	7
2015 Q2	$8.74M	Sell	385,000 -65,000	-14%	-$1.55M	1.85%	5
2015 Q1	$10.6M	Sell	450,000 -75,000	-14%	-$1.77M	1.43%	3
2014 Q4	$11.8M	Buy	525,000 +24,985	+5%	+$544K	3.14%	2
2014 Q3	$10.1M	Buy	500,015 +15	+0%	+$313	2.25%	6
2014 Q2	$10.7M	Buy	500,000 +25,000	+5%	+$515K	1.8%	4
2014 Q1	$9.51M	Buy	475,000 +25,000	+6%	+$448K	1.35%	6
2013 Q4	$7.85M	Hold	450,000	–	–	1.18%	10
2013 Q3	$7.63M	Buy	450,000 +50,000	+13%	+$853K	1.17%	11
2013 Q2	$7.33M	Buy	+400,000	New	+$7.37M	2.41%	7

Other funds holding TSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Howard Hughes Medical Institute's TSM Position: Q1 2026 in Review

Howard Hughes Medical Institute opened a new position in TSMC (TSM) in Q1 2026: 66,773 shares worth $22.6M. The stake represents 5.43% of the portfolio and ranks #7 among its holdings. This is a return to the name: Howard Hughes Medical Institute previously reported a position in TSM as recently as Q4 2022.

Howard Hughes Medical Institute first reported a position in TSM in Q2 2013 and has held it in 40 quarters since. 3,258 funds tracked by Wall St. Rank hold TSM as of Q1 2026.

Howard Hughes Medical Institute held 66,773 shares of TSMC worth $22.6M as of Q1 2026.
TSMC was a new Howard Hughes Medical Institute position in Q1 2026.
TSMC made up 5.43% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #7 holding.
Howard Hughes Medical Institute first reported a position in TSMC in Q2 2013 and has held it in 40 quarters since.
3,258 funds tracked by Wall St. Rank held TSMC as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.